Pharmacokinetics of Alternative Administration Routes of Melatonin: A Systematic Review

被引:59
作者
Zetner, D. [1 ]
Andersen, L. P. H. [1 ]
Rosenberg, J. [1 ]
机构
[1] Univ Copenhagen, Herlev Hosp, Dept Surg, Ctr Perioperat Optimizat, DK-2730 Herlev, Denmark
关键词
bioavailability; intranasal; transdermal; transmucosal; subcutaneous;
D O I
10.1055/s-0035-1565083
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Melatonin is traditionally administered orally but has a poor and variable bioavailability. This study aims to present an overview of studies investigating the pharmacokinetics of alternative administration routes of melatonin. Methods: A systematic literature search was performed and included experimental or clinical studies, investigating pharmacokinetics of alternative administration routes of melatonin in vivo. Alternative administration routes were defined as all administration routes except oral and intravenous. Results: 10 studies were included in the review. Intranasal administration exhibited a quick absorption rate and high bioavailability. Transdermal administration displayed a variable absorption rate and possible deposition of melatonin in the skin. Oral transmucosal administration of melatonin exhibited a high plasma concentration compared to oral administration. Subcutaneous injection of melatonin displayed a rapid absorption rate compared to oral administration. Conclusion: Intranasal administration of melatonin has a large potential, and more research in humans is warranted. Transdermal application of melatonin has a possible use in a local application, due to slow absorption and deposition in the skin. Oral transmucosal administration may potentially be a clinically relevant due to avoiding first-pass metabolism. Subcutaneous injection of melatonin did not document any advantages compared to other administration routes.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 26 条
[1]   Use of Transdermal Melatonin Delivery to Improve Sleep Maintenance During Daytime [J].
Aeschbach, D. ;
Lockyer, B. J. ;
Dijk, D-J ;
Lockley, S. W. ;
Nuwayser, E. S. ;
Nichols, L. D. ;
Czeisler, C. A. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (04) :378-382
[2]  
Bangha E, 1997, SKIN PHARMACOL, V10, P298
[3]  
Bartoli A., 2012, J BIOEQUIV BIOAVAILA, V4, P96, DOI [10.4172/jbb.1000120, DOI 10.4172/JBB.1000120]
[4]   Intranasal absorption of melatonin in vivo bioavailability study [J].
Bechgaard, E ;
Lindhardt, K ;
Martinsen, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (01) :1-5
[5]   Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: A crossover study with melatonin [J].
Benes, L ;
Claustrat, B ;
Horriere, F ;
Geoffriau, M ;
Konsil, J ;
Parrott, KA ;
DeGrande, G ;
McQuinn, RL ;
Ayres, JW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (10) :1115-1119
[6]   Effects of preoperative oral melatonin medication on postoperative analgesia, sleep quality, and sedation in patients undergoing elective prostatectomy: a randomized clinical trial [J].
Borazan, Hale ;
Tuncer, Sema ;
Yalcin, Naime ;
Erol, Atilla ;
Otelcioglu, Seref .
JOURNAL OF ANESTHESIA, 2010, 24 (02) :155-160
[7]   The clinical impact of Preoperative melatonin on postoperative outcomes in patients undergoing abdominal hysterectomy [J].
Caumo, Wolnei ;
Torres, Fernanda ;
Moreira, Nivio L., Jr. ;
Auzani, Forge A. S. ;
Monteiro, Cristiano A. ;
Londero, Gustavo ;
Ribeiro, Diego F. M. ;
Hidalgo, Maria Paz L. .
ANESTHESIA AND ANALGESIA, 2007, 105 (05) :1263-1271
[8]   The absolute bioavailability of oral melatonin [J].
DeMuro, RL ;
Nafziger, AN ;
Blask, DE ;
Menhinick, AM ;
Bertino, JS .
JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (07) :781-784
[9]   Variable bioavailability of oral melatonin [J].
Di, WL ;
Kadva, A ;
Johnston, A ;
Silman, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) :1028-1029
[10]  
Fourtillan JB, 2000, BIOPHARM DRUG DISPOS, V21, P15, DOI 10.1002/1099-081X(200001)21:1<15::AID-BDD215>3.0.CO